A Randomized Non-Comparative Phase II Study of Anti-Programmed Cell Death-Ligand 1 Atezolizumab or Chemotherapy as Second-Line Therapy in Patients With Small Cell Lung Cancer: Results From the IFCT-160…

Overview of attention for article published in Journal of Thoracic Oncology, January 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter: 2 X users
patent: 1 patent

facebook: 1 Facebook page
guideline: 2 clinical guideline sources

Readers on

mendeley: 97 Mendeley

So far, Altmetric has seen 2 Guidelines that reference this research output.

Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline

Clinical guideline published by American Society of Clinical Oncology (ASCO) on 11 Oct 2023

The American Society of Clinical Oncology (ASCO) is a leading organization dedicated to advancing cancer care through research, education, and clinical practice. ASCO provides evidence-based clinical guidelines to support oncologists in delivering optimal patient care and improving outcomes.

Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆

Clinical guideline published by European Society for Medical Oncology (ESMO) on 20 Apr 2021

The European Society for Medical Oncology (ESMO) is a leading organization dedicated to advancing cancer care through education, research, and clinical practice guidelines. It provides a professional network for oncologists, offering resources like clinical practice guidelines, educational courses, and access to oncology journals.

This page shows the most recent posts that mention this research output. Click here to find out how to access more activity.